
Henlius
About Henlius
Henlius Biopharmaceuticals, Inc. is a Biotechnology company located in 48860 Milmont Dr, Fremont, California, United States.
Recent News
Regulatory Actions for April 30, 2026
Henlius Receives the NMPA IND Clearance for HLX319 (Biosimilar, Phesgo)
Henlius Receives US FDA IND Clearance for HLX05-N (Biosimilar, Erbitux)
Henlius and Organon Receive the EC Approval for Poherdy (Biosimilar, Perjeta)
AACR San Diego 2026: New Drugs on the Horizon
Sun Pharma Says Talk of $10bn Organon Bid Is 'Speculative'
Eisai Gains Henlius Therapy; LB Pharma Snags $100M in Funding
DemeRx Reports the US FDA IND Application Acceptance to Advance DMX-1001 for Alcohol Use Disorder
Henlius Receives NMPA IND Clearance for HLX18 (Biosimilar, Opdivo)
Recent Deals
No recent deals for this company.